Artelo Biosciences market cap ARTL
Share price times shares outstanding: what the whole company sells for, since 2019.
- Today, Nov 2, 2026
- $1.1M
- Highest close in our data
- $13.9M
- Feb 2021
Artelo Biosciences is worth $1.1M at the close on Nov 2, 2026, at $2.17 a share.
That is up 15% over the last year and down 88% over five years.
Its highest close in our data was $13.9M in Feb 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $1.1M | $854.6K | $7.5M | +11% |
| 2025 | $1M | $898.6K | $4.4M | −12% |
| 2024 | $1.1M | $1M | $1.8M | −23% |
| 2023 | $1.5M | $1.2M | $3.1M | −46% |
| 2022 | $2.8M | $2.4M | $7.1M | −62% |
| 2021 | $7.3M | $5M | $13.9M | +99% |
| 2020 | $3.7M | $686.4K | $3.7M | +12% |
| 2019 | $3.3M | $2.1M | $3.9M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Artelo Biosciences' size, closest first, today.
| Company | Market cap |
|---|---|
| ARTLArtelo Biosciences | $1.1M |
| GOVXGeoVax Labs | $1.2M |
| MTNBMatinas BioPharma | $1.3M |
| LNAILunai Bioworks | $830.7K |
| NXTSNexentis Technologies | $772.3K |
| KAPAKairos Pharma, LTD. | $1.6M |
| OGENOragenics | $1.7M |
| ELABPMGC | $1.7M |
| JUNSJupiter Neurosciences | $1.8M |
| DCOYDecoy Therapeutics | $678.1K |
| GNPXGenprex | $1.8M |
| Peer median | $1.4M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Artelo Biosciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.